Lutein plus Zeaxanthin ( DrugBank: Lutein, Zeaxanthin )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 164 | Oculocutaneous albinism | 1 |
164. Oculocutaneous albinism
Clinical trials : 15 / Drugs : 57 - (DrugBank : 34) / Drug target genes : 35 - Drug target pathways : 139
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02200263 (ClinicalTrials.gov) | November 2014 | 23/7/2014 | The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism | A Randomized Placebo-controlled Trial to Investigate the Effect of Lutein and Zeaxanthin Supplementation on Macular Pigment and Visual Function in Albinism - LUtein for VIsion in Albinism (LUVIA) | Ocular Albinism (OA);Oculocutaneous Albinism (OCA) | Dietary Supplement: Lutein plus Zeaxanthin;Dietary Supplement: Placebo | Johns Hopkins University | Clark Charitable Foundation Inc. | Completed | 12 Years | N/A | All | 10 | N/A | United States |